TekanBio has been dedicated to developing high potency anti-cancer drug molecules, and its intermediates, and targeted drug delivery systems, especially antibody-drug conjugate (ADC) systems. By owning a strong R&D team led by doctors and postdoctors, and a professional drug R&D center located in Shanghai.